{"protocolSection": {"identificationModule": {"nctId": "NCT01277783", "orgStudyIdInfo": {"id": "ALSYNC"}, "organization": {"fullName": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}, "briefTitle": "ALternate Site Cardiac ReSYNChronization (ALSYNC) Study", "officialTitle": "ALternate Site Cardiac ReSYNChronization Study", "acronym": "ALSYNC"}, "statusModule": {"statusVerifiedDate": "2019-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-03"}, "primaryCompletionDateStruct": {"date": "2014-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-10", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-01-11", "studyFirstSubmitQcDate": "2011-01-14", "studyFirstPostDateStruct": {"date": "2011-01-17", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-10-19", "resultsFirstSubmitQcDate": "2019-03-20", "resultsFirstPostDateStruct": {"date": "2019-06-20", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-03-20", "lastUpdatePostDateStruct": {"date": "2019-06-20", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The ALternate site cardiac reSYNChronization (ALSYNC) study, a non-comparative, prospective, non-randomized, multi-national clinical investigation.\n\nThe purpose of this clinical investigation is to evaluate the safety and performance of the investigational atrial transseptal endocardial LV lead delivery system and the implant procedure for delivering the SelectSecure\u00ae Model 3830 lead into the Left Ventricle via a superior approach, and to evaluate the performance of the SelectSecure\u00ae Model 3830 lead in the Left Ventricle.", "detailedDescription": "Cardiac resynchronization therapy (CRT) reduces mortality and the risk of heart failure decompensation and improves quality of life in indicated patients. However, many do not benefit due to failure to deliver the left ventricular (LV) lead via coronary sinus (5-10%) or lack of symptomatic improvement (30-40%).\n\nThe purpose of the ALSYNC Study was to evaluate the feasibility and safety of LV endocardial (LVE) pacing using a Model 3830 lead implanted by a novel pectoral atrial transseptal lead delivery system."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 138, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Endocardial Left Ventricular pacing", "type": "EXPERIMENTAL", "description": "All patients will undergo the intervention, and are followed at 1, 3, 6, and 12 months (minimum) and biannually thereafter until 1 year after enrollment of the last patient.", "interventionNames": ["Device: Endocardial Left Ventricular pacing"]}], "interventions": [{"type": "DEVICE", "name": "Endocardial Left Ventricular pacing", "description": "Subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter, using trans esophageal echo (TEE) or intra-cardiac echo (ICE) to guide the procedure.", "armGroupLabels": ["Endocardial Left Ventricular pacing"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Percentage of Patients Free From Lead, Delivery System and Implant Related Complications.", "description": "Adverse events were reviewed by an independent Adverse Event Adjudication Committee. Events classified as complication related to the LV endocardial lead, the investigational delivery system or the implant procedure contribute to the outcome. The percentage of patients free from such complication at 6 months after the procedure was estimated using the Kaplan-Meier method and is reported with the corresponding 95% confidence interval.", "timeFrame": "6 months"}], "secondaryOutcomes": [{"measure": "Implant Success", "description": "Number of participants with a successful implant of Model 3830 lead.", "timeFrame": "Implant"}, {"measure": "Number of Questionnaires Reporting None of the Handling and Implant Characteristics as Poor", "description": "Questionaires were collected for each LV lead implant attempt, reattempt, and LV lead modification. To evaluate the ease of positioning of the Model 3830 lead and the Models 6227ATS and 6248HS, JS, JL catheters, a rating scale of Poor, Fair, Good, Very good, and Excellent was used for each of the ten questions on the questionnaire. Outcome reports the number of questionnaires where no single question was answered with Poor.", "timeFrame": "Implant"}, {"measure": "Bipolar Sensing Amplitude of the Model 3830 Lead in the LV at 12 Months", "description": "Sensing amplitude measurement was taken with the implanted device at the 12 month follow-up visit.", "timeFrame": "12 months"}, {"measure": "Bipolar Pacing Threshold of the Model 3830 Lead in the LV at 12 Months", "description": "Bipolar measurement of Model 3830 lead voltage threshold at 0.4ms pulse width using the implanted device at the 12 month visit", "timeFrame": "12 months"}, {"measure": "Bipolar Pacing Impedance of the Model 3830 Lead in the LV at 12 Months", "description": "Measurement of Impedance of the Model 3830 Lead in the LV using the implanted device at the 12 month visit", "timeFrame": "12 months"}, {"measure": "Subjects With 1 Class of NYHA Improvement From Baseline to 6 Months", "description": "NYHA Class change was evaluated between baseline and the 6 months visit. Reported are the subjects with at least 1 class improvement from baseline to 6 months", "timeFrame": "baseline and 6 months"}, {"measure": "Distance Walked at 6 Minute Hall Walk at the 12 Month Visit", "description": "Distance walked at the 6 minute hall walk test at the 12 month visit", "timeFrame": "12 months"}, {"measure": "Percent Change in Left Ventricular Ejection Fraction From Baseline to 6 Months", "description": "Percent change in Left Ventricular Ejection Fraction (LVEF) was measured from baseline to 6 months", "timeFrame": "baseline and 6 months"}, {"measure": "Milliliters Change in Left Ventricular End-Systolic Volume at 6 Months", "description": "Milliliters change in Left Ventricular End-Systolic Volume (LVESV) from baseline to 6 months", "timeFrame": "6 months"}, {"measure": "Millimeters Change in Left Ventricular End-Diastolic Diameter From Baseline to 6 Months", "description": "Millimeters change in Left Ventricular End-Diastolic Diameter (LVEDD) from baseline to 6 months", "timeFrame": "baseline and 6 months"}, {"measure": "Number of Subjects With Mitral Regurgitation Improvement of at Least One Class From Baseline to 6 Months", "description": "Reported is the number of patients with at least one class improvement from baseline to 6 months", "timeFrame": "baseline and 6 months"}, {"measure": "Change in (NT-pro)BNP Levels From Baseline to 6 Months", "description": "Change in either Brain Natriuretic Peptide (BNP) or N-Terminal-prohormone BNP (NT-proBNP) levels from baseline to 6 months", "timeFrame": "baseline and 6 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Cardiac Resynchronization Therapy candidate/recipient with:\n* Failed Cardiac Resynchronization Therapy implant or required CRT replacement without viable access to Coronary sinus or,\n* Sub-optimal Coronary sinus anatomy per investigator discretion or,\n* Worsened or unchanged clinical status after Cardiac Resynchronization Therapy implant\n* Patients able and willing to take optimal Vitamin K antagonist therapy (International Normalized Ratio (INR) of 2-4)\n* Patients willing to sign and date the Patient Informed Consent form\n* Patients 18 years of age or older\n* Patients able and willing to comply with the protocol, and is expected to remain available for follow-up visits\n\nExclusion Criteria:\n\n* Patients having contraindications to Vitamin K antagonist therapy\n* Patients contraindicated for \\< 100 micrograms beclomethasone dipropionate\n* Patients unable to tolerate an urgent thoracotomy\n* Documented (previous) ischemic or hemorrhagic stroke\n* Patients with known previous atrial septal defect closure, or history of mural thrombus that has not been resolved\n* Patients with documented atrial fibrillation AND increased stroke risk as determined by the Congestive Heart Failure, Hypertension, Age(2), Diabetes, Stroke(2), Vascular disease, Age, and Sex Category (CHA2DS2-VASc) Score of equal to or greater than 5\n* Patients with unstable angina pectoris or who have had an acute myocardial infarct within the past 30 days\n* Patients with known atrial septum defect (ASD) and/or left superior vena cava\n* Patient with known internal carotid artery stenosis of greater than 50%\n* Patients diagnosed with peripheral artery disease that are expected to undergo stenting within the next three months\n* Patients who have had a Coronary artery bypass graft or stent within the past three months\n* Patients with history of mitral or aortic valve repair or replacement\n* Post heart transplant patients (patients waiting for heart transplant are allowed in the study)\n* Patients currently undergoing dialysis treatment\n* Patients with ongoing chemotherapy and radiation therapy that may have an effect on cardiac function\n* Patients with ongoing Adverse Events from a previous Left Ventricle lead implant attempt\n* Patients enrolled in any concurrent drug and/or device study that may confound the results of this study\n* Patients who are not expected to survive more than twelve months\n* Patients with exclusion criteria required by local law", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Professor John Morgan, MD", "affiliation": "Spire Southampton Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "AZ Sint-Jan - Campus Sint-Jan", "city": "Brugge", "country": "Belgium", "geoPoint": {"lat": 51.20892, "lon": 3.22424}}, {"facility": "Centre Hospitalier Regional de la Citadelle", "city": "Li\u00e8ge", "country": "Belgium", "geoPoint": {"lat": 50.63373, "lon": 5.56749}}, {"facility": "Saint Paul's Hospital", "city": "Vancouver", "state": "British Columbia", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "London Health Sciences Centre - University Campus", "city": "London", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "H\u00f4pital Haut-L\u00e9v\u00eaque - CHU de Bordeaux", "city": "Bordeaux", "country": "France", "geoPoint": {"lat": 44.84044, "lon": -0.5805}}, {"facility": "CHU Grenoble H\u00f4pital Michalon", "city": "Grenoble", "country": "France", "geoPoint": {"lat": 45.16667, "lon": 5.71667}}, {"facility": "Infirmerie Protestante de Lyon", "city": "Lyon", "country": "France", "geoPoint": {"lat": 45.74848, "lon": 4.84669}}, {"facility": "Nouvelles Cliniques Nantaises", "city": "Nantes", "country": "France", "geoPoint": {"lat": 47.21725, "lon": -1.55336}}, {"facility": "H\u00f4pital Pontchaillou - CHU de Rennes", "city": "Rennes", "country": "France", "geoPoint": {"lat": 48.11198, "lon": -1.67429}}, {"facility": "Semmelweis Egyetem AOK", "city": "Budapest", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant' Orsola - Malpighi", "city": "Bologna", "country": "Italy", "geoPoint": {"lat": 44.49381, "lon": 11.33875}}, {"facility": "Presidio Ospedaliero Alessandro Manzoni", "city": "Lecco", "country": "Italy", "geoPoint": {"lat": 45.85589, "lon": 9.39704}}, {"facility": "Azienda Complesso Ospedaliero San Filippo Neri Ospedale San Filippo Neri", "city": "Roma", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "Academisch Ziekenhuis Maastricht (AZM)", "city": "Maastricht", "country": "Netherlands", "geoPoint": {"lat": 50.84833, "lon": 5.68889}}, {"facility": "Royal Victoria Hospital", "city": "Belfast", "country": "United Kingdom", "geoPoint": {"lat": 54.59682, "lon": -5.92541}}, {"facility": "Golden Jubilee National Hospital", "city": "Glasgow", "country": "United Kingdom", "geoPoint": {"lat": 55.86515, "lon": -4.25763}}, {"facility": "University College London Hospitals NHS Foundation Trust - The Heart Hospital", "city": "London", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "Southampton General Hospital", "city": "Southhampton", "country": "United Kingdom", "geoPoint": {"lat": 50.90395, "lon": -1.40428}}]}, "referencesModule": {"references": [{"pmid": "29579617", "type": "DERIVED", "citation": "Biffi M, Defaye P, Jais P, Ruffa F, Leclercq C, Gras D, Yang Z, Gerritse B, Ziacchi M, Morgan JM; ALSYNC Investigators. Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study. Int J Cardiol. 2018 May 15;259:88-93. doi: 10.1016/j.ijcard.2018.01.030."}, {"pmid": "26787437", "type": "DERIVED", "citation": "Morgan JM, Biffi M, Geller L, Leclercq C, Ruffa F, Tung S, Defaye P, Yang Z, Gerritse B, van Ginneken M, Yee R, Jais P; ALSYNC Investigators. ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. Eur Heart J. 2016 Jul 14;37(27):2118-27. doi: 10.1093/eurheartj/ehv723. Epub 2016 Jan 18."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "LV Endocardial Lead", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 3830: Endocardial Left Ventricular pacing"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "138"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "138"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "All enrolled subjects meeting eligibility criteria are included in the baseline analysis population. 2 subjects were not included from the overall number of subjects that completed the study because they had a major eligibility violation (both had left superior vena cava).", "groups": [{"id": "BG000", "title": "Left Ventricular Endocardial Pacing", "description": "All enrolled patients were scheduled to receive a CRT implantation with endocardial LV lead"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "136"}]}], "measures": [{"title": "Age, Customized", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"title": "Age (years)", "categories": [{"measurements": [{"groupId": "BG000", "value": "66", "spread": "10"}]}]}]}, {"title": "Sex/Gender, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Gender (male)", "categories": [{"measurements": [{"groupId": "BG000", "value": "106"}]}]}]}, {"title": "New York Heart Association (NYHA) Class", "description": "Classification of symptoms:\n\nClass I=No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea.\n\nClass II=Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.\n\nClass III=Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nClass IV=Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "NYHA Class I", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "NYHA Class II", "measurements": [{"groupId": "BG000", "value": "29"}]}, {"title": "NYHA Class III", "measurements": [{"groupId": "BG000", "value": "93"}]}, {"title": "NYHA Class IV", "measurements": [{"groupId": "BG000", "value": "10"}]}]}]}, {"title": "Atrial Fibrillation", "description": "Number of subjects that have Atrial Fibrillation at baseline", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "68"}]}]}]}, {"title": "Left Bundle Branch Block (LBBB)", "description": "Number of subjects that have LBBB at baseline", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "94"}]}]}]}, {"title": "QRS duration", "description": "The duration in milliseconds (ms) of the QRS complex in the subject's electrocardiogram at baseline.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "milliseconds (ms)", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "165", "spread": "32"}]}]}]}, {"title": "Left Ventricular Ejection Fraction (LVEF)", "description": "The percentage of blood leaving the heart each time it contracts", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "percentage", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "29", "spread": "9"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Percentage of Patients Free From Lead, Delivery System and Implant Related Complications.", "description": "Adverse events were reviewed by an independent Adverse Event Adjudication Committee. Events classified as complication related to the LV endocardial lead, the investigational delivery system or the implant procedure contribute to the outcome. The percentage of patients free from such complication at 6 months after the procedure was estimated using the Kaplan-Meier method and is reported with the corresponding 95% confidence interval.", "populationDescription": "The Analysis cohort (132) includes the Baseline cohort (136) (Enrolled patients (138), excluding patients exited for eligibility violation without implant attempt and patients removed for major eligibility violation (2)), excluding patients that did not have implant attempt (4).", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of patients", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "LV Endocardial Lead", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "82.2", "lowerLimit": "75.6", "upperLimit": "88.8"}]}]}]}, {"type": "SECONDARY", "title": "Implant Success", "description": "Number of participants with a successful implant of Model 3830 lead.", "populationDescription": "The Analysis cohort (132) includes the Baseline cohort (136) (Enrolled patients (138), excluding patients exited for eligibility violation without implant attempt and patients removed for major eligibility violation (2)), excluding patients that did not have implant attempt (4).", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Implant", "groups": [{"id": "OG000", "title": "LV Endocardial Lead", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "118"}]}]}]}, {"type": "SECONDARY", "title": "Number of Questionnaires Reporting None of the Handling and Implant Characteristics as Poor", "description": "Questionaires were collected for each LV lead implant attempt, reattempt, and LV lead modification. To evaluate the ease of positioning of the Model 3830 lead and the Models 6227ATS and 6248HS, JS, JL catheters, a rating scale of Poor, Fair, Good, Very good, and Excellent was used for each of the ten questions on the questionnaire. Outcome reports the number of questionnaires where no single question was answered with Poor.", "populationDescription": "Participants analyzed are those in the Analysis cohort as described before (132). The unit of analysis is a questionnaire for each attempted Model 3820 lead implant (139). In 7 cases their was a repeat procedure (reported as repeat implant attempt or system modification).", "reportingStatus": "POSTED", "paramType": "COUNT_OF_UNITS", "unitOfMeasure": "questionnaire", "timeFrame": "Implant", "typeUnitsAnalyzed": "questionnaire", "denomUnitsSelected": "questionnaire", "groups": [{"id": "OG000", "title": "LV Endocardial Lead", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery\n\nMedtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}, {"units": "questionnaire", "counts": [{"groupId": "OG000", "value": "139"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "75"}]}]}]}, {"type": "SECONDARY", "title": "Bipolar Sensing Amplitude of the Model 3830 Lead in the LV at 12 Months", "description": "Sensing amplitude measurement was taken with the implanted device at the 12 month follow-up visit.", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 24 patients had a missing 12-months follow-up visit and 5 had a missing R-wave amplitude measurement", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Bipolar Sensing Amplitude in milliVolts", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "11", "spread": "6.4"}]}]}]}, {"type": "SECONDARY", "title": "Bipolar Pacing Threshold of the Model 3830 Lead in the LV at 12 Months", "description": "Bipolar measurement of Model 3830 lead voltage threshold at 0.4ms pulse width using the implanted device at the 12 month visit", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 24 patients had a missing 12-months follow-up visit and 4 had a missing bipolar pacing threshold measurement", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Bipolar LV pacing threshold in Volts", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "90"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.84", "spread": "0.27"}]}]}]}, {"type": "SECONDARY", "title": "Bipolar Pacing Impedance of the Model 3830 Lead in the LV at 12 Months", "description": "Measurement of Impedance of the Model 3830 Lead in the LV using the implanted device at the 12 month visit", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 24 patients had a missing 12-months follow-up visit and 3 had a missing impedance measurement", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Bipolar LV Pacing Impedance in Ohms", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "596", "spread": "80"}]}]}]}, {"type": "SECONDARY", "title": "Subjects With 1 Class of NYHA Improvement From Baseline to 6 Months", "description": "NYHA Class change was evaluated between baseline and the 6 months visit. Reported are the subjects with at least 1 class improvement from baseline to 6 months", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 13 patients had a missing 6-months follow-up visit.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "baseline and 6 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "105"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "62"}]}]}]}, {"type": "SECONDARY", "title": "Distance Walked at 6 Minute Hall Walk at the 12 Month Visit", "description": "Distance walked at the 6 minute hall walk test at the 12 month visit", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 24 patients had a missing 12-months follow-up visit, and 18 did not complete the test.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Distance walked in meters", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "76"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "391", "spread": "147"}]}]}]}, {"type": "SECONDARY", "title": "Percent Change in Left Ventricular Ejection Fraction From Baseline to 6 Months", "description": "Percent change in Left Ventricular Ejection Fraction (LVEF) was measured from baseline to 6 months", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 18 patients had a missing LVEF measurement at baseline and/or 6 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent change in LVEF", "timeFrame": "baseline and 6 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "100"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "36.1", "spread": "12.0"}]}]}]}, {"type": "SECONDARY", "title": "Milliliters Change in Left Ventricular End-Systolic Volume at 6 Months", "description": "Milliliters change in Left Ventricular End-Systolic Volume (LVESV) from baseline to 6 months", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 27 patients had a missing LVESV measurement at baseline and/or 6 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "LVESV change in milliliters", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "91"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "121", "spread": "74"}]}]}]}, {"type": "SECONDARY", "title": "Millimeters Change in Left Ventricular End-Diastolic Diameter From Baseline to 6 Months", "description": "Millimeters change in Left Ventricular End-Diastolic Diameter (LVEDD) from baseline to 6 months", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 17 patients had a missing LVEDD measurement at baseline and/or 6 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "millimeters change in LVEDD", "timeFrame": "baseline and 6 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "63.7", "spread": "9.9"}]}]}]}, {"type": "SECONDARY", "title": "Number of Subjects With Mitral Regurgitation Improvement of at Least One Class From Baseline to 6 Months", "description": "Reported is the number of patients with at least one class improvement from baseline to 6 months", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 16 patients had a missing MR measurement at baseline and/or 6 months.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "baseline and 6 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "102"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "33"}]}]}]}, {"type": "SECONDARY", "title": "Change in (NT-pro)BNP Levels From Baseline to 6 Months", "description": "Change in either Brain Natriuretic Peptide (BNP) or N-Terminal-prohormone BNP (NT-proBNP) levels from baseline to 6 months", "populationDescription": "Of the 118 patients that were successfully implanted with the Model 3830 lead in the LV, 22 patients had a missing (NTpro)BNP measurement at baseline and/or 6 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "change in picograms per milliliter", "timeFrame": "baseline and 6 months", "groups": [{"id": "OG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"title": "BNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "31"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "444", "spread": "587"}]}]}, {"title": "NT-proBNP", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2554", "spread": "3485"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Serious adverse events are reported with onset between the start of the LV endocardial implant procedure and the end of follow-up, which was after 17.3 months on average.", "description": "Serious adverse events are reported for the 132 patients that had an attempt to implant an endocardial LV lead. Implantation was successful for 118 patients.", "eventGroups": [{"id": "EG000", "title": "Left Ventricular Endocardial Pacing", "description": "subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter and guidance of TEE or ICE.\n\nMedtronic Model 6227ATS deflectable delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter: Endocardial Left Ventricular pacing lead delivery Medtronic Model 3830: Endocardial Left Ventricular pacing", "deathsNumAffected": 23, "deathsNumAtRisk": 132, "seriousNumAffected": 86, "seriousNumAtRisk": 132, "otherNumAffected": 49, "otherNumAtRisk": 132}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 132}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Atrial thrombosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 30, "numAtRisk": 132}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac tamponade", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiogenic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Electromechanical dissociation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Intracardiac thrombus", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Mitral valve incompetence", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Ventricular arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 132}]}, {"term": "Macular oedema", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Retinal artery thrombosis", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Dysphagia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Haematemesis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Melaena", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Rectal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Retroperitoneal haematoma", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac failure", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site haematoma", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 132}]}, {"term": "Presyncope", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Sudden cardiac death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Systemic inflammatory response syndrome", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Ischaemic hepatitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Bronchopneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Device related infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Erysipelas", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pilonidal cyst", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Septic shock", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Staphylococcal infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Wound infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac vein perforation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Clavicle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Delayed recovery from anaesthesia", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Device dislocation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Device lead damage", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Device migration", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Implant site reaction", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Lead dislodgement", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 132}]}, {"term": "Wound dehiscence", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "International normalised ratio decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Hypokalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Chondrocalcinosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Foot deformity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Acute myeloid leukaemia", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Gastric cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Meningioma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Neoplasm malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Prostate cancer recurrent", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 132}]}, {"term": "Cognitive disorder", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Neuropathy peripheral", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 132}]}, {"term": "Device psychogenic complication", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Diabetic nephropathy", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Urinary retention", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Bronchitis chronic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Bronchopulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Haemothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Respiratory distress", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Skin lesion", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cardiac failure", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Extrusion of device", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Peripheral revascularisation", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Arterial disorder", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 132}]}], "otherEvents": [{"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 132}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Atrial tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 132}]}, {"term": "Intracardiac thrombus", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cataract", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Metamorphopsia", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Abdominal discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Gastric ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Oesophageal disorder", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Rectal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Adverse drug reaction", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Asthenia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site fibrosis", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site haematoma", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 132}]}, {"term": "Oedema", "organSystem": "General disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 132}]}, {"term": "Catheter related infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Cystitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Localised infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Inappropriate device stimulation of tissue", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Inappropriate device therapy", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Lead dislodgement", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "International normalised ratio increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Troponin", "organSystem": "Investigations", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Gout", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Limb discomfort", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Musculoskeletal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Myalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Carpal tunnel syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Convulsion", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Migraine with aura", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Neuralgia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Parkinson's disease", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Vascular dementia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Confusional state", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Urinary retention", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}, {"term": "Hyperventilation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Idiopathic pulmonary fibrosis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Respiratory disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Blister", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Erythema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Pruritus", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Skin lesion", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Transient acantholytic dermatosis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 132}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Implant site haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 132}]}, {"term": "Orthostatic hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA v12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 132}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Mireille van Ginneken, Principal Clinical Research Specialist", "organization": "Medtronic Bakken Research Center B.V.", "email": "mireille.vanginneken@medronic.com", "phone": "+31433566801"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}